Table 1.
Subject characteristics of the pediatric cohort (n = 228).
| N | Sex (M:F) | Age(years) a | SARS-CoV-2 PCR and/or serology positive | Time from symptoms onset to blood draw (days) a | |
|---|---|---|---|---|---|
| Healthy pediatric controls | 16 | 7:9 | 6.5 [3-13] | NA | NA |
| Acute febrile infection, unrelated to SARS-CoV-2 or KD | 15 | 4:11 | 10 [8-12] | NA | 8 [7-10] |
| KD-acute phase | 39 b | 29:10 | 9 [8-10] | NA | 8 [7-11] |
| KD-subacute phase | 37 b | 26:11 | 8 [7-11] | NA | 40 [37-45] |
| Children with COVID-19 | 59 | 41:18 | 1 [0.7-9] | 59 (100%) | 2 [0-6] |
| Children recovered from COVID-19 | 8 | 7:1 | 14 [11-15] | 8/8 | 52 [30-142] |
| MIS-C | 54 | 29:25 | 6 [2-11] | 54 (100%) | 3 [1-9] c |
a
Values in square brackets represent the median and interquartile range.
b
Ten of the same patients with Kawasaki disease (KD) in the acute and subacute phase were represented.
c
For MIS-C, time is defined as the day of the first blood draw obtained after hospitalization.
NA, Not applicable.